Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Use and Acceptability of HIV Self-Testing Among First-Time Testers at Risk for HIV in Senegal.

Lyons CE, Coly K, Bowring AL, Liestman B, Diouf D, Wong VJ, Turpin G, Castor D, Dieng P, Olawore O, Geibel S, Ketende S, Ndour C, Thiam S, Touré-Kane C, Baral SD.

AIDS Behav. 2019 Jun 13. doi: 10.1007/s10461-019-02552-2. [Epub ahead of print]

PMID:
31197701
2.

[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study].

Cohen D, Shimakawa Y, Ndow G, Sow A, Tamba S, Njie R, Lo G, Ghosh S, Toure-Kane C, Ka M, Mboup S, Okeke E, Toure S, Diop M, D'Alessandro U, Taylor-Robinson S, Mendy M, Zoulim F, Thursz MR, Lemoine M, Chemin I.

Med Sci (Paris). 2019 May;35(5):431-439. doi: 10.1051/medsci/2019076. Epub 2019 May 22. French.

PMID:
31115326
3.

Effectiveness of the prevention of HIV mother -to-child transmission (PMTCT) program via early infant diagnosis (EID) data in Senegal.

Gueye SB, Diop-Ndiaye H, Diouf O, Sow-Ndoye A, Touré F, Ngom-Faye NF, Diagne-Gueye D, Mbow-Ndiaye K, Niang Diallo PA, Gaye-Diallo A, Mboup S, Ndour CT, Boye CS, Touré-Kane C.

PLoS One. 2019 May 21;14(5):e0215941. doi: 10.1371/journal.pone.0215941. eCollection 2019.

4.

Characterizing the Influence of Structural Determinants of HIV Risk on Consistent Condom Use Among Female Sex Workers in Senegal.

Twahirwa Rwema JO, Lyons CE, Ketende S, Bowring AL, Rao A, Comins C, Diouf D, Drame FM, Liestman B, Coly K, Ndour C, Turpin G, Mboup S, Toure-Kane C, Castor D, Leye-Diouf N, Diop-Ndiaye H, Baral S.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):63-71. doi: 10.1097/QAI.0000000000001991.

PMID:
30865185
5.

High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal.

Cissé AM, Laborde-Balen G, Kébé-Fall K, Dramé A, Diop H, Diop K, FatouNiasse-Traoré, Coulibaly M, Have NN, Vidal N, Thiam S, Wade AS, Peeters M, Taverne B, Msellati P, Touré-Kane C.

BMC Pediatr. 2019 Feb 5;19(1):47. doi: 10.1186/s12887-019-1420-z.

6.

Evaluation of Senegal's prevention of mother to child transmission of HIV (PMTCT) program data for HIV surveillance.

Diouf O, Gueye-Gaye A, Sarr M, Mbengue AS, Murrill CS, Dee J, Diaw PO, Ngom-Faye NF, Diallo PAN, Suarez C, Gueye M, Mboup A, Toure-Kane C, Mboup S.

BMC Infect Dis. 2018 Nov 20;18(1):588. doi: 10.1186/s12879-018-3504-z.

7.

Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir.

Villabona-Arenas CJ, Eymard-Duvernay S, Aghokeng A, Guichet E, Toure-Kane C, Bado G, Koulla-Shiro S, Delaporte E, Ciaffi L, Peeters M.

AIDS Res Hum Retroviruses. 2018 Jun;34(6):477-480. doi: 10.1089/AID.2017.0290. Epub 2018 Apr 23.

PMID:
29575909
8.

Screening strategies to prevent mother-to-child transmission of hepatitis B in sub-Saharan Africa.

Shimakawa Y, Seck A, Nayagam S, Toure-Kane C, Lemoine M.

Lancet Gastroenterol Hepatol. 2018 Apr;3(4):222-223. doi: 10.1016/S2468-1253(18)30033-5. Epub 2018 Mar 7. No abstract available.

9.

ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens.

Rodgers MA, Vallari AS, Yamaguchi J, Holzmayer V, Harris B, Toure-Kane C, Mboup S, Badreddine S, McArthur C, Ndembi N, Mbanya D, Kaptue L, Cloherty G.

AIDS Res Hum Retroviruses. 2018 Mar;34(3):314-318. doi: 10.1089/AID.2017.0244. Epub 2018 Feb 13.

10.

HIV viral load monitoring among key populations in low- and middle-income countries: challenges and opportunities.

Schwartz SR, Kavanagh MM, Sugarman J, Solomon SS, Njindam IM, Rebe K, Quinn TC, Toure-Kane C, Beyrer C, Baral S.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25003.

11.

Desulfovibrio senegalensis sp. nov., a mesophilic sulfate reducer isolated from marine sediment.

Thioye A, Gam ZBA, Mbengue M, Cayol JL, Joseph-Bartoli M, Touré-Kane C, Labat M.

Int J Syst Evol Microbiol. 2017 Sep;67(9):3162-3166. doi: 10.1099/ijsem.0.001997. Epub 2017 Sep 4.

PMID:
28867000
12.

HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo.

Niama FR, Vidal N, Diop-Ndiaye H, Nguimbi E, Ahombo G, Diakabana P, Bayonne Kombo ÉS, Mayengue PI, Kobawila SC, Parra HJ, Toure-Kane C.

BMC Res Notes. 2017 Jul 5;10(1):243. doi: 10.1186/s13104-017-2550-8.

13.

Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.

Ndow G, Gore ML, Shimakawa Y, Suso P, Jatta A, Tamba S, Sow A, Touré-Kane C, Sadiq F, Sabally S, Njie R, Thursz MR, Lemoine M.

PLoS One. 2017 Jun 14;12(6):e0179025. doi: 10.1371/journal.pone.0179025. eCollection 2017.

14.

Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.

Lyons CE, Ketende S, Diouf D, Drame FM, Liestman B, Coly K, Ndour C, Turpin G, Mboup S, Diop K, Toure-Kane C, Castor D, Leye-Diouf N, Baral S.

J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S52-S59.

15.

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.

Lemoine M, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I, Ghosh S, Njai HF, Jeng A, Sow A, Toure-Kane C, Mboup S, Suso P, Tamba S, Jatta A, Sarr L, Kambi A, Stanger W, Nayagam S, Howell J, Mpabanzi L, Nyan O, Corrah T, Whittle H, Taylor-Robinson SD, D'Alessandro U, Mendy M, Thursz MR; PROLIFICA investigators.

Lancet Glob Health. 2016 Aug;4(8):e559-67. doi: 10.1016/S2214-109X(16)30130-9.

16.

[Use of dried blood spots in early diagnosis of HIV-1 infection in children born to HIV-infected mothers as part of the prevention of mother-to-child transmission in Benin].

Tchiakpe E, Hounto-Ogouyemi A, Diop Ndiaye H, Diouara AA, Aïssi AK, Keke RK, Kpangon AA, Lafia B, Métadokou D, Bouraïma B, Anthony D, Hounsinou A, Alao MJ, Azondekon A, Ahouidi AD, Bei AK, Mbengue MA, Touré Kane C, Zannou DM.

Bull Soc Pathol Exot. 2016 Aug;109(3):155-9. doi: 10.1007/s13149-016-0509-y. Epub 2016 Jul 7. French.

PMID:
27385037
17.

Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa.

Guichet E, Aghokeng A, Serrano L, Bado G, Toure-Kane C, Eymard-Duvernay S, Villabona-Arenas CJ, Delaporte E, Ciaffi L, Peeters M.

AIDS Res Hum Retroviruses. 2016 Dec;32(12):1159-1162. Epub 2016 Aug 2.

PMID:
27342228
18.

COFAC-Col: A Cervical Cancer Control Networking Initiative in Five French-Speaking African Countries.

Berthet N, Berling C, Nabi H, Woto Gaye G, Toure Kane C, Diop-Ndiaye H, Koumakpayi IH, Engohan Aloghe C, Bisvigou U, Didi Coulibaly J, Faye Kette H, Koffi E, Ekra D, Moussavou Boundzanga P, Labouba I, NJouom R, Tebeu PM, Sandjong I, Atangana PA, N'Kegoum B, Rakoto-Andrianarivelo M, Rakotomalala FA, Randrianjafisamindrakotroka N, Andriamampionona TF, Ratovohery A, Sastre-Garau X, Diop M.

Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):1004-5. doi: 10.1158/1055-9965.EPI-15-1248. Epub 2016 Mar 23. No abstract available.

19.

Mother-to-child transmission of hepatitis B in sub-Saharan Africa.

Shimakawa Y, Toure-Kane C, Mendy M, Thursz M, Lemoine M.

Lancet Infect Dis. 2016 Jan;16(1):19-20. doi: 10.1016/S1473-3099(15)00469-7. No abstract available.

PMID:
26738828
20.

Performance of Roche CAP/CTM HIV-1 qualitative test version 2.0 using dried blood spots for early infant diagnosis.

Gueye SB, Diop-Ndiaye H, Diallo MM, Ly O, Sow-Ndoye A, Diagne-Gueye ND, Kébé-Fall K, Diop F, Gaye-Diallo A, Belec L, Mboup S, Touré-Kane C.

J Virol Methods. 2016 Mar;229:12-5. doi: 10.1016/j.jviromet.2015.12.006. Epub 2015 Dec 17.

PMID:
26706730
21.

Response to comments by Hønge et al. on our paper titled "Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients".

Lô G, Sow-Sall A, Diop-Ndiaye H, Mandiouba NC, Thiam M, Diop F, Ndiaye O, Gueye SB, Seck SM, Diouara AA, Mbow M, Gaye-Diallo A, Mboup S, Touré-Kâne C.

J Med Virol. 2016 Oct;88(10):1655-6. doi: 10.1002/jmv.24452. Epub 2016 Jun 22. No abstract available.

PMID:
26696555
22.

Low prevalences of HIV infection and HSV genital shedding in the general adult female population in Senegal.

Diawara S, Bélec L, Dem A, Mbaye S, Diop Ndiaye H, Matta M, Bousso Gueye S, Mboup S, Toure Kane C.

J Infect Dev Ctries. 2015 Nov 30;9(11):1272-6. doi: 10.3855/jidc.6227.

23.

HBV carriage in children born from HIV-seropositive mothers in Senegal: The need of birth-dose HBV vaccination.

Gueye SB, Diop-Ndiaye H, Lo G, Mintsa S, Guindo I, Dia A, Sow-Sall A, Gaye-Diallo A, Mboup S, Touré-Kane C.

J Med Virol. 2016 May;88(5):815-9. doi: 10.1002/jmv.24409. Epub 2015 Nov 4.

PMID:
26488892
24.

Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.

Lô G, Sow-Sall A, Diop-Ndiaye H, Mandiouba NC, Thiam M, Diop F, Ndiaye O, Gueye SB, Seck SM, Dioura AA, Mbow M, Gaye-Diallo A, Mboup S, Touré-Kâne C.

J Med Virol. 2016 Mar;88(3):461-5. doi: 10.1002/jmv.24344. Epub 2015 Aug 20.

PMID:
26252424
25.

Comparison of four commercial viral load techniques in an area of non-B HIV-1 subtypes circulation.

Ndiaye O, Diop-Ndiaye H, Ouedraogo AS, Fall-Malick FZ, Sow-Sall A, Thiam M, Diouara AA, Ndour CT, Gaye-Diallo A, Mboup S, Toure-Kane C; Study Group.

J Virol Methods. 2015 Sep 15;222:122-31. doi: 10.1016/j.jviromet.2015.06.002. Epub 2015 Jun 9.

PMID:
26068392
26.

Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa.

Njai HF, Shimakawa Y, Sanneh B, Ferguson L, Ndow G, Mendy M, Sow A, Lo G, Toure-Kane C, Tanaka J, Taal M, D'alessandro U, Njie R, Thursz M, Lemoine M.

J Clin Microbiol. 2015 Apr;53(4):1156-63. doi: 10.1128/JCM.02980-14. Epub 2015 Jan 28.

27.

Performance of the Abbott Real Time CT/NG assay in urines and cervico-vaginal samples from Senegal.

Gueye SB, Diop-Ndiaye H, Gningue A, Ndiaye O, Mbengue AS, Gaye-Diallo A, Ndjioyi A, Mboup S, Touré-Kane C.

J Infect Dev Ctries. 2014 Jul 14;8(7):898-903. doi: 10.3855/jidc.4026.

28.

[The challenges of training in medical laboratories in Africa].

Mboup S, Gershy-Damet GM, Touré Kane C, Bélec L.

Med Sante Trop. 2014 Jul-Sep;24(3):237-40. doi: 10.1684/mst.2014.0349. French.

29.

Chryseobacterium indologenes in a woman with acute leukemia in Senegal: a case report.

Omar A, Camara M, Fall S, Ngom-Cisse S, Fall B, Ba-Diallo A, Diop-Ndiaye H, Toure-Kane C, Mboup S, Gaye-Diallo A.

J Med Case Rep. 2014 May 6;8:138. doi: 10.1186/1752-1947-8-138.

30.

Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M; ANRS 12235 Study Group.

J Clin Microbiol. 2014 Feb;52(2):578-86. doi: 10.1128/JCM.02860-13. Epub 2013 Dec 11.

31.

The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.

Kébé K, Bélec L, Diop Ndiaye H, Bousso Gueye S, Abdallah Malick Diouara A, Ngom S, Rama Diagne Gueye N, Mbaye N, Signaté Sy H, Mboup S, Touré Kane C.

J Int AIDS Soc. 2014 Jan 16;17:18526. doi: 10.7448/IAS.17.1.18526. eCollection 2014.

32.

Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania.

Fall-Malick FZ, Tchiakpé E, Ould Soufiane S, Diop-Ndiaye H, Mouhamedoune Baye A, Ould Horma Babana A, Touré Kane C, Lo B, Mboup S.

J Med Virol. 2014 Mar;86(3):404-10. doi: 10.1002/jmv.23860. Epub 2013 Dec 7.

PMID:
24318486
33.

Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LX, Delaporte E, Chaix ML, Peeters M, Ayouba A; ANRS 12186 Study Group.

Clin Infect Dis. 2014 Jan;58(1):99-109. doi: 10.1093/cid/cit627. Epub 2013 Sep 27.

PMID:
24076968
34.

High frequency of HIV-1 infections with multiple HIV-1 strains in men having sex with men (MSM) in Senegal.

Leye N, Vidal N, Ndiaye O, Diop-Ndiaye H, Wade AS, Mboup S, Delaporte E, Toure-Kane C, Peeters M.

Infect Genet Evol. 2013 Dec;20:206-14. doi: 10.1016/j.meegid.2013.09.002. Epub 2013 Sep 11.

PMID:
24035811
35.

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.

Dieye TN, Ndiaye BP, Dieng AB, Fall M, Brittain N, Vermaak S, Camara M, Diop-Ndiaye H, Ngom-Gueye NF, Diaw PA, Toure-Kane C, Sow PS, Mboup S, McShane H.

PLoS One. 2013 Jun 28;8(6):e67177. doi: 10.1371/journal.pone.0067177. Print 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/67550546-cacf-4063-8d62-d165da14ca61. Britain, Nathaniel [corrected to Brittain, Nathaniel].

36.

HIV type 1 subtype C remains the predominant subtype in men having sex with men in Senegal.

Ndiaye HD, Tchiakpe E, Vidal N, Ndiaye O, Diop AK, Peeters M, Mboup S, Toure-Kane C.

AIDS Res Hum Retroviruses. 2013 Sep;29(9):1265-72. doi: 10.1089/AID.2013.0140. Epub 2013 Jul 19.

PMID:
23742654
37.

Performance of the ViroSeq HIV-1 genotyping system v2.0 on HIV-1 strains circulating in Senegal.

Thiam M, Diop-Ndiaye H, Kebe K, Vidal N, Diakhate-Lô R, Diouara AA, Leye N, Ndiaye O, Sow A, Ngom-Gueye NF, Mboup S, Toure-Kane C.

J Virol Methods. 2013 Mar;188(1-2):97-103. doi: 10.1016/j.jviromet.2012.11.044. Epub 2012 Dec 21.

PMID:
23266258
38.

HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system.

Thiam M, Diop-Ndiaye H, Diouf AD, Vidal N, Ndiaye O, Ndiaye I, Ngom-Gueye NF, Diallo S, Diongue OD, Camara M, Seck A, Mboup S, Toure-Kane C.

J Clin Microbiol. 2013 Feb;51(2):578-84. doi: 10.1128/JCM.02452-12. Epub 2012 Dec 12.

39.

A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa.

Vidal N, Diop H, Montavon C, Butel C, Bosch S, Ngole EM, Touré-Kane C, Mboup S, Delaporte E, Peeters M.

Infect Genet Evol. 2013 Mar;14:73-82. doi: 10.1016/j.meegid.2012.11.017. Epub 2012 Dec 8.

PMID:
23232100
40.

Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort.

De Beaudrap P, Thiam M, Diouf A, Toure-Kane C, Ngom-Guèye NF, Vidal N, Mboup S, Ndoye I, Sow PS, Delaporte E; ANRS 1215 Study Group.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):381-7. doi: 10.1097/QAI.0b013e31827a2a7a.

PMID:
23117504
41.

High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.

Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A, Signate Sy H, Charpentier C, Belec L, Mboup S, Toure Kane C.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):242-9. doi: 10.1089/aid.2011.0300. Epub 2012 Aug 3.

PMID:
22860571
42.

The origin and evolutionary history of HIV-1 subtype C in Senegal.

Jung M, Leye N, Vidal N, Fargette D, Diop H, Toure Kane C, Gascuel O, Peeters M.

PLoS One. 2012;7(3):e33579. doi: 10.1371/journal.pone.0033579. Epub 2012 Mar 28.

43.

Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents.

Dieye TN, Diaw PA, Daneau G, Wade D, Sylla Niang M, Camara M, Diallo AA, Toure Kane C, Diop Ndiaye H, Mbengue B, Dieye A, Kestens L, Mboup S.

J Immunol Methods. 2011 Sep 30;372(1-2):7-13. doi: 10.1016/j.jim.2011.07.012. Epub 2011 Jul 29. Review.

PMID:
21835181
44.

Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal.

Diop-Ndiaye H, Toure-Kane C, Leye N, Ngom-Gueye NF, Montavon C, Peeters M, Mboup S.

AIDS Res Hum Retroviruses. 2010 Oct;26(10):1133-8. doi: 10.1089/aid.2009.0295. Epub 2010 Sep 19.

PMID:
20849302
45.

CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL.

Niama FR, Vidal N, Bazepeo SE, Mpoudi E, Toure-Kane C, Parra HJ, Delaporte E, Peeters M.

AIDS Res Hum Retroviruses. 2009 Dec;25(12):1345-53. doi: 10.1089/aid.2009.0169.

PMID:
20001521
46.

Tenofovir-emtricitabine-efavirenz in HIV-I-infected adults in Senegal: a 96-week pilot trial in treatment-naive patients.

Landman R, Poupard M, Diallo M, Ngom Gueye NF, Diakhate N, Ndiaye B, Toure Kane C, Trylesinski A, Diop H, Mboup S, Koita Fall MB, Delaporte E, Benalycherif A, Girard PM, Sow PS.

J Int Assoc Physicians AIDS Care (Chic). 2009 Nov-Dec;8(6):379-84. doi: 10.1177/1545109709344352. Epub 2009 Sep 15.

PMID:
19755618
47.

Surprisingly high prevalence of subtype C and specific HIV-1 subtype/CRF distribution in men having sex with men in Senegal.

Ndiaye HD, Toure-Kane C, Vidal N, Niama FR, Niang-Diallo PA, Dièye T, Gaye-Diallo A, Wade AS, Peeters M, Mboup S.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):249-52. doi: 10.1097/QAI.0b013e3181af70a4.

PMID:
19553825
48.

African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent.

Kaleebu P, Abimiku A, El-Halabi S, Koulla-Shiro S, Mamotte N, Mboup S, Mugerwa R, Nkengasong J, Toure-Kane C, Tucker T, Wassenaar D, Williamson C, Wolday D.

PLoS Med. 2008 Dec 2;5(12):e236. doi: 10.1371/journal.pmed.0050236. No abstract available.

49.

[Decentralization of the immunological monitoring of people living with HIV/AIDS in a limiting setting with a low HIV seroprevalence: the experience of Senegal].

Diaw PA, Sylla Niang M, Touré Kane C, Dieye TD, Diop Ndiaye H, Wade AS, Dieye A, Mboup S.

Ann Biol Clin (Paris). 2008 Jul-Aug;66(4):409-16. doi: 10.1684/abc.2008.0239. French.

50.

Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).

Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S.

J Med Virol. 2008 Aug;80(8):1332-6. doi: 10.1002/jmv.21236.

PMID:
18551596

Supplemental Content

Loading ...
Support Center